Cited by 608Pain Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsPain Management and Treatment

The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines

Austin, Paul J., Moalem-Taylor, Gila·2010·Journal of Neuroimmunology

Abstract

In a large proportion of individuals nervous system damage may lead to a debilitating chronic neuropathic pain. Such pain may now be considered a neuro-immune disorder, since recent data indicate a critical involvement of innate and adaptive immune responses following nerve injury. Activation of immune and immune-like glial cells in the injured nerve, dorsal root ganglia and spinal cord results in the release of both pro- and anti-inflammatory cytokines, as well as algesic and analgesic mediators, the balance of which determines whether pain chronicity is established. This review will critically examine the role of the immune system in modulating chronic pain in animal models of nervous system injury, and highlight the possible therapeutic opportunities to intervene in the development and maintenance of neuropathic pain.

Integrity signals

Registry

Crossref · 10.1016/j.jneuroim.2010.08.013

Cites

399 of 399 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Neuropathic pain pathophysiology is complex and includes functional alterations of the CNS and PNS in addition to neuro-immune interactions.

    “Neuropathic pain pathophysiology is complex and includes functional alterations of the CNS and PNS (Cohen and Mao, 2014) in addition to neuro-immune interactions (Austin and Moalem-Taylor, 2010).”
  • Five nights of partial sleep deprivation lead to a reduction of stimulated IL-2 production in healthy humans.

    “Five nights of partial sleep deprivation led to a reduction of stimulated IL-2 production in healthy humans (24), which is in line with the studies manipulating sleep for only one night.”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [24]

  • Sleep, by favoring pro-inflammatory and Th1 cytokine production, supports the interaction between APCs and T cells and the subsequent differentiation and proliferation of Th1 cells, eventually leading to the formation of IgG1 and IgG3 antibodies.

    “In addition, sleep, by favoring pro-inflammatory and Th1 cytokine production, further supports the interaction between APCs and T cells and the subsequent differentiation and proliferation of Th1 cells, eventually leading to the formation of IgG1 and IgG3 antibodies (24, 67, 148, 254, 320).”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [24]

  • A shift in the Th1/Th2 balance has been observed for alcohol dependence-associated sleep changes and in response to experimental sleep deficiency, and may explain lower vaccine efficacy and increased infection risk in the context of sleep deficiency.

    “Such a shift in the Th1/Th2 balance has been also observed for alcohol dependence-associated sleep changes (462) and in response to experimental sleep deficiency (24, 320), and may explain lower vaccine efficacy and increased infection risk in the context of sleep deficiency”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [24]

Cites

1 retracted

Flagged first, then by citations

2 of the 401 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Austin, P. J., & Moalem-Taylor, G.
Affiliations
UNSW Sydney (AU)
Corresponding author
Austin, Paul J.
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
2010-12
Volume
229
Issue
1-2
Pages
26-50
ISSN
0165-5728 (ISSN-L)
OpenAlex
W2111964682
Cited by
607
References
401
Citations by year
2026: 28 · 2025: 28 · 2024: 26 · 2023: 49 · 2022: 26 · 2021: 46 · 2020: 40 · 2019: 41 · 2018: 38 · 2017: 42 · 2016: 52 · 2015: 47 · 2014: 39 · 2013: 43 · 2012: 31
FWCI
3.41
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuroimmunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
Keywords
neuropathic pain, neuroimmune interactions, chronic pain, cytokines, dorsal root ganglia, spinal cord, nerve injury, pain chronicity
MeSH terms
Animals, Humans, Immune System, Inflammation, Nervous System, Neuralgia, Neuroglia, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review